US Product Portfolio for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedFolio
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
A major limiter preventing market growth in the dental bone graft substitute and other biomaterials markets is the tendency to supplement large-scale implant purchases with discounted, and even complimentary, DBGS materials. As periodontists and oral surgeons outnumber general practitioners (GPs) in terms of dentists placing implants in the United States, and as these specialists tend to buy in bulk, this trend is expected to persist in the future.
The growing number of GPs placing implants is driving the total markets for dental bone graft substitutes and other biomaterials forward by increasing the volume of dental implant procedures. Another result of more GPs trained on implants is that they are more knowledgeable over the critical factors necessary to achieve a successful implant procedure. Therefore, the increased number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate either a DBGS and membrane or a dental growth factor.
As in previous years, pre-existing materials within the market continue to be improved. Improvements are being made to every segment of the DBGS market. With regards to digital systems, the high growth rate of the dental implant industry has spurred the development and greater acceptance of technologies in the dental market that assist in greater efficiency in restoring dental implants; these technological advances, in turn, drive further placement of implants as they offer dentists greater assistance. The greater utilization of cone beam computed tomography (CBCT) scanners, which are modified versions of traditional CT scanners for dental applications, assists in designing accurate three-dimensional models of a patient’s jaw. Based on the three-dimensional model, imaging software can be used to diagnose the bone density and structure of the patient’s jaw structure that will provide much greater insight into the condition of the patient’s jaw. With regards to dental growth factors, the market is moving towards improving the convenience of handling the products. Handling characteristics are essential features of dental growth factor products. Due to their chemical and biological composition, these products are easier to apply than conventional bone graft materials. These products are often provided in a liquid format, allowing them to be combined with bone graft substitutes by end-users to suit their purposes. The current exception to this is Osteocel®, which must be kept frozen until ready for use.
The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.
- EXECUTIVE SUMMARY
- U.S. DENTAL BONE GRAFT SUBSTITUTES AND OTHER BIOMATERIALS MARKET OVERVIEW
- COMPETITIVE ANALYSIS
- MARKET TRENDS
- MARKET DEVELOPMENTS
- PROCEDURES COVERED
- MARKETS INCLUDED
- KEY REPORT UPDATES
- VERSION HISTORY
- RESEARCH METHODOLOGY
- 1.1 RESEARCH SCOPE
- 1.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- DISEASE OVERVIEW
- 2.1 BASIC ANATOMY
- 2.1.1 Dental Anatomy: Oral Cavity and Intraoral landmarks
- 2.2 DISEASE PATHOLOGY AND DISORDERS
- 2.2.1 General Diagnostics
- 2.2.2 Indication for Dental Implant
- 2.2.2.1 Periodontal Disease
- 2.2.2.2 Dental Implant Procedures
- 2.3 PATIENT DEMOGRAPHICS
- 2.3.1 General Dental Statistics
- 2.3.2 Tooth Loss Statistics
- PRODUCT ASSESSMENT
- 3.1 PRODUCT PORTFOLIOS
- 3.1.1 Dental Bone Graft Substitutes
- 3.1.1.1 Autografts
- 3.1.1.2 Allografts
- 3.1.1.3 Xenografts
- 3.1.1.4 Synthetics
- 3.1.1.5 Dental Barrier Membranes
- 3.1.1.6 Dental Growth Factor Products
- 3.2 REGULATORY ISSUES AND RECALLS
- 3.2.1 Dental Bone Graft Substitutes
- 3.3 CLINICAL TRIALS
- 3.3.1 Dental Bone Graft Substitutes
- ABBREVIATIONS
- APPENDIX: COMPANY PRESS RELEASES
- List of Charts
- Chart 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S., 2013 – 2023
- Chart 1 2: Dental Bone Graft Substitutes and Other Biomaterials Market Overview, U.S., 2016 & 2023
- List of Figures
- Figure 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market Share Ranking by Segment, U.S., 2016
- Figure 1 2: Companies Researched in this Report, U.S., 2016
- Figure 1 3: Factors Impacting the Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S.
- Figure 1 4: Recent Events in the Dental Bone Graft Substitutes and Other Biomaterials Market, U.S., 2013 – 2016
- Figure 1 5: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016
- Figure 1 6: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (1 of 2)
- Figure 1 7: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (2 of 2)
- Figure 1 8: Key Report Updates
- Figure 1 9: Version History
- Figure 3 1: Dental Bone Graft Substitute Products by Company (1 of 2)
- Figure 3 2: Dental Bone Graft Substitute Products by Company (2 of 2)
- Figure 3 3: Dental Barrier Membrane Products by Company (1 of 2)
- Figure 3 4: Dental Barrier Membrane Products by Company (2 of 2)
- Figure 3 5: Dental Growth Products by Company
- Figure 3 6: Class 3 Device Recall ZCORE Syringe
- Figure 3 7: Class 2 Device Recall Collagen Matrix Inc.
- Figure 3 8: Class 2 Device Recall Endobon Xenograft Granules, Biomet France SARL
- Figure 3 9: Class 3 Device Recall ENDOBON XENOGRAFT GRANULES 0.5 ML
- Figure 3 10: Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)
- Figure 3 11: Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane
- Figure 3 12: Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
- Figure 3 13: Guided Bone Regeneration Using Synthetic Membrane
- Figure 3 14: Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft
- Figure 3 15: A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants
- Figure 5 1: Press Release Summary